Blue light therapy shows promise for vitiligo repigmentation

NCT ID NCT07174024

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study compared blue light therapy to targeted narrow band UVB for treating stable non-segmental vitiligo in 30 patients. The goal was to see which treatment better restores skin color. Both are light-based therapies, but blue light may be less harsh on the skin.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

blue light emitting diode therapy and narrow band UVB phototherapy

What this could lead to

If blue light works as well as UVB, it could offer a gentler, more convenient option for repigmenting vitiligo patches.

What could go wrong

This is a small, completed Phase 4 trial with only 30 patients, so results may not apply to everyone. Blue light may be less effective or cause side effects like skin sensitivity.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VITILIGO are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

vitiligo

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cairo University

    Giza, Cairo Governorate, 13114, Egypt